Latest Breaking News On - Tca 650 - Page 1 : comparemela.com

FDA panel is gathering Sept. 21 to discuss ITCA 650, a Type 2 diabetes drug delivery product under review for possible approval. The experimental therapy has been denied approval twice.

United statesMetabolic drugs advisory committeeIntarcia therapeuticsTca 650Type 2 diabetesDrug deliveryIntarcia therapeuticsGlp 1